Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 332

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JMREH-6-2_007

تاریخ نمایه سازی: 22 تیر 1398

چکیده مقاله:

Background & aim: The developing countries have the contraceptive prevalence rate of 43%. Contraceptive discontinuation accounts for a large number of unintended pregnancies in these countries. The present study aimed to investigate the factors associated with Cyclofem discontinuation. Methods: This historical cohort study was conducted on 198 females, selected through cluster and Poisson sampling techniques. The first dose of Cyclofem was administered one month prior to the research. The data were collected using a questionnaire filled out through interviewing. Results: During the study period, only 3.94% of the health centers clients selected Cyclofem as a contraceptive method. The mean duration of Cyclofem use was 7.1±8.01 months. The likelihood of contraceptive continuation declined with increased consumption duration. Menstrual complications caused by this contraceptive method included irregular menstruation (35.4%) and neurological problems (14.6%). Furthermore, there were some personal reasons (8.1%) accounting for the discontinuation of this method. The frequency of Cyclofem use decreased with increased rate of menstrual irregularities (P=0.045) and spotting (P=0.020). Based on the participants’ reports, the most frequent complications were the medical ones. However, there was no significant difference between the females who continued Cyclofem use and those who discontinued (P=0.08). The majority of the participants reported no particular non-medical problems. The results revealed that the participants who used Cyclofem for a longer time stopped using this birth control method less commonly than those used it for a shorter time (P<0.001). Conclusion: As the findings indicated, the most common reason for the discontinuation of Cyclofem was its associated side effects, especially menstrual irrigularities. Therefore, the healthcare providers should emphasize on the adverse effects of Cyclofem prior to recommending this contraceptive method.

نویسندگان

Mansoore shariati

Lecturer, Department of Midwifery, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran

Azar Golmakany

Lecturer, Department of Midwifery, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran

Parviz Maroozi

Lecturer, Department of Epidemiology and Biostatistics, Mashhad University of Medical Sciences, Mashhad, Iran

Bahar Bayati

Lecturer, Department of Epidemiology and Biostatistics, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Fathizadeh N, Abdi F, Savabi M. A comparative study on ...
  • Ozgoli G, Sheikhan Z, Dolatian M, Simbar M, Bakhtyari M, ...
  • Homayounfar N, Sehhati F, Mardi A, Amani F, Jafarzadeh H. ...
  • Kamalifard M, Mohammad AS, Sadeghi H, Hasanzadeh R. Comparison of ...
  • Rahimy MH, Cromie MA, Hopkins NK, Tong DM. Lunelle™ monthly ...
  • Soltani R, Parsae S. Mother and child Health. 4th ed. ...
  • Shulman LP. Clinical trial results with MPA/E2C. The Journal of ...
  • Ali M, Cleland J, Shah I. Causes and consequences of ...
  • Simbar M, Ramezani F, Hashemi Z, Zham H, Bayat AM. ...
  • Sheikhi ZP, Kariman N, Sheikhan Z, Majd HA, Afrakhteh M, ...
  • Jamali B, Kiapoor A, Firoozbakht M, Kazeminavaei F, Taghlili F. ...
  • Koetsawang S. Once-a-month injectable contraceptives: efficacy and reasons for discon-tinuation. ...
  • Hall P, Bahamondes L, Diaz J, Petta C. Introductory study ...
  • Kazi AI. Comparative evaluation of two once-a-month contraceptive injections. Journal ...
  • Eslami M. Iranian’s students News Agency (ISNA). ISNA News Agency. ...
  • Hassan EO, El-Nahal N, El-Hussinie M. Once-a-month injectable contraceptives, cyclofem® ...
  • Guazzelli CA, de Mello Jacobucci MS, Barbieri M, Araújo FF, ...
  • Seidali A, Ahmadi M, Jannesari S, Alavimajd H. Comparison of ...
  • Ruminjo JK, Sekadde-Kigondu CB, Karanja JG, Rivera R, Nasution M, ...
  • Kariman N, Pahlavani Sheykhi Z, Majd Alavi H. Comparison of ...
  • Pandi SP, Hadjar LN, Prihyugiharto T. Introductory trial of the ...
  • Hall PE. The introduction of Cyclofem into national family planning ...
  • Speroff L, Darney PD. A clinical guide for contraception. Philadelphia: ...
  • Hall PE. New once‐a‐month injectable contraceptives, with particular reference to ...
  • Farrokh Eslamlou H, Eslami M, Haji-Shafiha M. Introducing Cyclofem as ...
  • de Cetina TE, Luna MO, Canto JA, Bassol S. Menstrual ...
  • Fraser I. Vaginal bleeding patterns in women using once-a-month injectable ...
  • de Mello Jacobucci MS, Guazzelli CA, Barbieri M, Araújo FF, ...
  • Kaunitz AM, Garceau RJ, Cromie MA, Lunelle Study Group. Comparative ...
  • Safavi NK, Zandi F. The comparative of combined oral contraceptives ...
  • Piya-Anant M, Koetsawang S, Patrasupapong N, Dinchuen P, d Arcangues ...
  • World Health Organization. Ensuring human rights in the provision of ...
  • نمایش کامل مراجع